ANDRE JUICE (02218): Li Yufeng has been appointed to replace Yu Haifeng as the signing registered accountant.

17:51 05/03/2026

Andi Juice (02218) announced that Tian Tong Firm will be the company's financial auditing firm and internal control auditing firm for the year 2025. Originally, Mr. Wang Desheng (project partner) and Mr. Yu Haifeng were assigned as the signing certified public accountants to provide audit services for the company. Due to internal rearrangements at Tian Tong Firm, Ms. Li Yufeng has been appointed to replace Mr. Yu Haifeng as the signing certified public accountant for the company's 2025 audit project to complete the audit of financial statements. The updated signing certified public accountants are Mr. Wang Desheng and Ms. Li Yufeng, with no changes in the project quality review personnel.

ANDRE JUICE (02218) issued a notice, appointing the company as the 2025 financial audit and internal control audit institutions. Originally, Mr. Wang Desheng (project partner) and Mr. Yu Haifeng were appointed as the signing certified public accountants to provide auditing services for the company. Due to internal adjustments at the company, Ms. Li Yufeng has now been appointed to replace Mr. Yu Haifeng as the signing certified public accountant for the company's 2025 annual audit project, to complete the audit of the financial statements. The updated signing certified public accountants are Mr. Wang Desheng and Ms. Li Yufeng, with no changes to the project quality review team.

MEITUAN-W(03690) cancels 3.017 million repurchased shares.

Shenzhen Han's CNC Technology (03200): Fully exercise the over-allotment option, stabilize the price movement, and the stabilization period ends.

HUTCHMED (00013) announces annual performance with a net profit attributable to shareholders of $457 million USD, a year-on-year increase of 1111.03%.

MEITUAN-W(03690) cancels 3.017 million repurchased shares.

Shenzhen Han's CNC Technology (03200): Fully exercise the over-allotment option, stabilize the price movement, and the stabilization period ends.

HUTCHMED (00013) announces annual performance with a net profit attributable to shareholders of $457 million USD, a year-on-year increase of 1111.03%.